Literature DB >> 15623494

Plasma nitrotyrosine in reversible myocardial ischaemia.

A Elfatih1, N R Anderson, S Mansoor, S Ahmed, R Horton, M R Holland, R Gama.   

Abstract

BACKGROUND: Nitric oxide (NO) plays a vital role in vascular homeostasis and in the pathophysiology of coronary heart disease. Its metabolites, nitrite and nitrate, have vasculoprotective properties, whereas peroxynitrite, an oxidant metabolite of NO, is cytotoxic and can aggravate myocardial damage during ischaemic reperfusion injury. Peroxynitrite nitrates free and protein bound tyrosine residues to produce nitrotyrosine. The measurement of nitrotyrosine provides an indirect estimation of plasma peroxynitrite concentrations. AIMS: To measure plasma nitrotyrosine concentrations to see whether peroxynitrite could contribute to myocardial dysfunction during myocardial ischaemia induced by an exercise tolerance test (ETT). MATERIALS/
METHODS: Plasma free nitrotyrosine concentrations were compared before and after exercise in 29 subjects with a positive ETT and 34 subjects with a negative ETT.
RESULTS: Plasma nitrotyrosine concentrations were similar in patients with exercise induced myocardial ischaemia and controls.
CONCLUSION: Peroxynitrite does not contribute to the myocardial dysfunction in reversible myocardial ischaemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15623494      PMCID: PMC1770554          DOI: 10.1136/jcp.2004.018713

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Physiological effects of peroxynitrite: potential products of the environment.

Authors:  J Vinten-Johansen
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

Review 3.  Exercise tolerance testing.

Authors:  Jonathan Hill; Adam Timmis
Journal:  BMJ       Date:  2002-05-04

4.  Serum nitric oxide levels in patients with coronary artery disease.

Authors:  P Akarasereenont; T Nuamchit; A Thaworn; W Leowattana; S Chotewuttakorn; P Khunawat
Journal:  J Med Assoc Thai       Date:  2001-12

5.  Nitric oxide and peroxynitrite in postischemic myocardium.

Authors:  J L Zweier; J Fertmann; G Wei
Journal:  Antioxid Redox Signal       Date:  2001-02       Impact factor: 8.401

Review 6.  Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review.

Authors:  C Herce-Pagliai; S Kotecha; D E Shuker
Journal:  Nitric Oxide       Date:  1998       Impact factor: 4.427

7.  Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock.

Authors:  N Fukuyama; Y Takebayashi; M Hida; H Ishida; K Ichimori; H Nakazawa
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

Review 8.  The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury.

Authors:  C Szabó
Journal:  Shock       Date:  1996-08       Impact factor: 3.454

9.  Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.

Authors:  H Kaur; B Halliwell
Journal:  FEBS Lett       Date:  1994-08-15       Impact factor: 4.124

10.  An investigation of nitric oxide metabolites during symptomatic myocardial ischaemia in relation to exercise tolerance test.

Authors:  Abubaker Elfatih; Neil R Anderson; Syed Mansoor; Saqib Ahmed; Richard Horton; Martin Holland; Rousseau Gama
Journal:  Med Sci Monit       Date:  2003-12
View more
  1 in total

Review 1.  Nitrotyrosine, Nitrated Lipoproteins, and Cardiovascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?

Authors:  Grzegorz K Jakubiak; Grzegorz Cieślar; Agata Stanek
Journal:  Antioxidants (Basel)       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.